Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
Clinical trial NCT03798691 · COMPLETED
Trial details
- NCT number
- NCT03798691
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-28
- Primary completion
- 2023-10-12
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.